2022 annual financial data
Oncolytics Biotech 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -19,837,901 CAD and net income was -18,298,703 CAD.
Operating cash flow was -17,208,222 CAD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -19,837,901 CAD
- Net income
- -18,298,703 CAD
- Operating cash flow
- -17,208,222 CAD